Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03429400 · ClinicalTrials.gov registry record · Phase 3
Study of Oral Morphine Sulfate Administration in Pediatric Subjects
A Phase 3 study of Pain, Postoperative, sponsored by West-Ward Pharmaceutical.
- Completed
- Registry status
- Phase 3
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT03429400 is a Phase 3 study of Pain, Postoperative that has completed, run by West-Ward Pharmaceutical. The registered enrollment target is 51 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03429400, a Phase 3 study of Pain, Postoperative, has completed, sponsored by West-Ward Pharmaceutical.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multicenter, open-label study to evaluate the safety and PK of oral morphine sulfate in pediatric subjects with post-operative pain.
Conditions Studied
Interventions
- DRUG Morphine Sulfate
Study Locations (1)
Alabama
- Site 105 - Sheffield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2018-04-17 |
| Est. Completion | 2019-05-29 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03429400
The ClinicalTrials.gov registry entry for NCT03429400 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (81% lower). The listed sponsor is West-Ward Pharmaceutical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Morphine Sulfate is the first listed.
NCT03429400 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT03429400 about?
NCT03429400 is a clinical study titled "Study of Oral Morphine Sulfate Administration in Pediatric Subjects". This is a multicenter, open-label study to evaluate the safety and PK of oral morphine sulfate in pediatric subjects with post-operative pain.
What is the current status of trial NCT03429400?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 51 participants. The study started on 2018-04-17. Estimated completion is 2019-05-29.
What conditions does trial NCT03429400 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT03429400?
The interventions under investigation include: Morphine Sulfate (DRUG).
Who is sponsoring clinical trial NCT03429400?
This trial is sponsored by West-Ward Pharmaceutical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03429400 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
COMPLETED · Phase 3
-
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
COMPLETED · Phase 3
-
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.